Atlas Trials

A Study to Evaluate the Effect of Age on the Pharmacokinetics, Safety and Tolerability of IV Rivipansel.

Clinical trial NCT02998099 · COMPLETED

Trial details

NCT number
NCT02998099
Sponsor
GlycoMimetics Incorporated
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2017-01-01
Primary completion
2017-02-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.